PT  - JOURNAL ARTICLE
AU  - Nguyen, Thanh D.
AU  - Wen, Yan
AU  - Du, Jingwen
AU  - Spincemaille, Pascal
AU  - Wang, Yi
AU  - Qi, Yang
AU  - Kamel, Hooman
AU  - Gupta, Ajay
TI  - Quantitative susceptibility mapping improves the detection of calcified carotid vessels by multi-contrast MRI using computed tomography angiography as the reference standard
AID  - 10.1101/2021.07.07.21260049
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.07.21260049
4099  - http://medrxiv.org/content/early/2021/07/08/2021.07.07.21260049.short
4100  - http://medrxiv.org/content/early/2021/07/08/2021.07.07.21260049.full
AB  - The objective of this study was to evaluate initial feasibility and improvement in the detection of calcified carotid arteries by including quantitative susceptibility mapping (QSM) in the carotid vessel wall multi-contrast MRI (mcMRI) protocol using CTA as the reference standard. In a pilot cohort of ten patients with significant carotid artery stenosis, calcified vessel detection by mcMRI achieved 64.7% sensitivity and 100% specificity. Adding QSM to mcMRI improved sensitivity to 100% while not affecting specificity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Weill Cornell Medical College IRB (IRB organizational number IORG#0000617)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available to interested researchers upon reasonable request.